PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 121 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $1,000 | -80.0% | 600 | -92.7% | 0.00% | – |
Q2 2017 | $5,000 | -93.5% | 8,200 | -94.7% | 0.00% | -100.0% |
Q1 2017 | $77,000 | +1440.0% | 154,000 | +5316.8% | 0.00% | – |
Q4 2016 | $5,000 | +400.0% | 2,843 | -75.3% | 0.00% | – |
Q3 2016 | $1,000 | -80.0% | 11,500 | +296.6% | 0.00% | – |
Q2 2016 | $5,000 | -86.8% | 2,900 | -76.2% | 0.00% | -100.0% |
Q1 2016 | $38,000 | -24.0% | 12,200 | -5.4% | 0.00% | +50.0% |
Q4 2015 | $50,000 | – | 12,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
IFP Advisors, Inc | 0 | $0 | 0.00% |
NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |